Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study.

Benesch, M

Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study. [electronic resource] - Bone marrow transplantation Dec 2003 - 1071-5 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0268-3369

10.1038/sj.bmt.1704277 doi


Adult
Amifostine--administration & dosage
Busulfan--administration & dosage
Cause of Death
Cytoprotection--drug effects
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Middle Aged
Myeloablative Agonists--administration & dosage
Myelodysplastic Syndromes--complications
Pilot Projects
Siblings
Transplantation Conditioning--adverse effects
Transplantation, Homologous
Treatment Outcome
Whole-Body Irradiation